Wave Life Sciences (WVE) Interest & Investment Income (2015 - 2026)
Wave Life Sciences' (WVE) quarterly Interest & Investment Income came in at $4.7 million in Q2 2026, up 99.07% YoY from $2.4 million in Q2 2025, and down 10.75% on a QoQ basis from $5.3 million in Q1 2026.
Analysis
Wave Life Sciences (WVE) Interest & Investment Income (2015 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 7 years of Interest & Investment Income data on file, last reported at $4.7 million in Q2 2026.
- Quarterly Interest & Investment Income rose 99.07% year-over-year to $4.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.2 million (up 41.37% YoY) and the FY2025 annual result came in at $10.5 million, up 3.1% from the prior year.
- Interest & Investment Income slipped to $4.7 million in Q2 2026, from $5.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q1 2026 to a low of $26000.0 in Q1 2022.
- A 5-year average of $2.2 million and a median of $2.1 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 16400.0% — and 2025, when it fell 18.3%.
- Tracing WVE's Interest & Investment Income over 5 years: stood at $825000.0 in 2022, then jumped by 123.52% to $1.8 million in 2023, then soared by 102.71% to $3.7 million in 2024, then decreased by 18.3% to $3.1 million in 2025, then jumped by 54.62% to $4.7 million in 2026.
- The last three Interest & Investment Income figures came in at $4.7 million (Q2 2026), $5.3 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Wave Life Sciences | 983.14 Mn | 615.13 Mn | - | 4.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.72 Mn |
| Mar 31, 2026 | 5.29 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 124,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |